Hotline Numbers:

+91 9289151047, +91 9811437895

Project Report on Bulk Drugs [Eiri-1495]

Project Report on Bulk Drugs [Eiri-1495]

35000 INR/Piece

Product Details:


Project Report on Bulk Drugs [Eiri-1495] Price And Quantity

  • 1 Piece
  • 35000 INR/Piece

Project Report on Bulk Drugs [Eiri-1495] Trade Information

  • 1 Piece Per Day
  • 2-3 Days
  • All India

Product Description

Bulk Drugs [Eiri-1495]

A bulk drug also called active pharmaceutical ingredient (API) is the chemical molecule in a pharmaceutical product (medicines we buy from the chemist) that lends the product the claimed therapeutic effect. In other words, it is the substance responsible for the product being a medicine, penicillin to give one example. As is evident from this, there are ingredients other than the API in products sold as medicines. These inactive ingredients - excipients may or may not change from product to product, while the bulk drug would inevitably remain the same as it is the identity of the medicine. When the bulk drug is absent, the product is no longer a medicine and when it is changed, it is a new medicine. One may ask if the existence of the inactive ingredients signify anything to the patient. In the case of most of the existing bulk drugs, change of inactive ingredients don't impact the curative quality of the product, although there are exceptions. This means the drug manufacturers more or less have the liberty to "formulate" the bulk drug using excipents of his choice depending on chemical feasibility and commercial interests. The medicines in the markets in the "form" of tablets, capsules, syrups, drops, intravenous fluids etc., are therefore "formulations." In plain language, the products we refer to as medicines are formulations (of bulk drugs) and not bulk drugs per se.

Cost Estimation

Plant Capacity                            1333.33 KGS/Day
Land & Building (3570    Rs. 3.88 Cr.
Plant & Machinery                      Rs. 5.32 Cr.        
W.C. for 3 Months                      Rs. 5.58 Cr.          
Total Capital Investment               Rs. 15.38 Cr.             
Rate of Return                             64%  
Break Even Point                         40%

Note: ITI can modify the Capacity and Project Cost based on your requirement.

Contents of the Project Reports

Uses and Applications
Market Position
Present Manufacturers
Detailed Process of Manufacture
B.I.S. Specifications
Process Flow Sheet Diagram, Plant Layout,
Cost Economics with Profitability Analysis
Land & Building Requirements with Rates
List & Details of Plant and Machinery with their Costs
Raw Materials Details/List and Costs
Power & Water Requirements
Labour/Staff Requirements
Utilities and Overheads
Total Capital Investment
Cost of Production
Break Even Point
Land Man Ratio
Suppliers of Plant & Machineries and Raw Materials
Cash Flow Statement
Repayment Schedule
Interest Chart
Depreciation Chart
Projected Balance Sheet for 5 Years etc.
Enter Buying Requirement Details
Email Id
Mobile number

Other Products in 'Project Report on Pharmaceuticals Technology' category

Account Holder Name: Industrial Technologies, India

Current Account Number: 3312 1123 908


MICR CODE : 110002141

Bank Address: State Bank of India, Hauz Quazi, Delhi 110006, India

Back to top